Antiviral peptide and use thereof
AssigneesToagosei Co., Ltd., National University Corporation Hokkaido University
InventorsTetsuhiko Yoshida, Ayato Takada, Nahoko Baileykobayashi
Life of this patent
Estimating the term…
Abstract
The synthetic peptide disclosed here includes (1) an amino acid sequence represented by any of SEQ ID NOS:1 to 10, or a modified amino sequence formed by deletion, substitution or addition of 1, 2 or 3 amino acid residues in any of these amino acid sequences, together with (2) an amino acid sequence (CPP sequence) that functions as a cell penetrating peptide (CPP), and consists of a total of not more than 100 amino acid residues.
Claims2
A synthetic peptide that suppresses proliferation of at least one kind of virus, comprising the amino acid sequence represented by any of SEQ ID NOs:29 to 35, wherein the total number of amino acid residues in the synthetic peptide is not more than 100.
An antiviral composition for suppressing proliferation of at least one kind of virus, comprising, a synthetic peptide comprising the amino acid sequence represented by any of SEQ ID NOs:29 to 35, and at least one kind of pharmacologically acceptable carrier, wherein the total number of amino acid residues in the synthetic peptide is not more than 100.
Dependencies are inferred from the claim text.